
Keywords: HIV; human immunodeficiency virus; TB; tuberculosis; FBDD; fragment-based drug discovery; HTS; high-throughput screening; SPR; surface plasmon resonance; Mtb; Mycobacterium tuberculosis; Mab; Mycobacterium abscessus; INH; isoniazid; PZA; pyrazinamide; NTM